Elevated MMP2 expression in fibrotic interstitial lung disease: a potential biomarker for assessment of disease severity

Key Points

• Elevated MMP2 expression correlates with increased disease severity in patients with fibrotic interstitial lung disease.
• A significant association is observed between MMP2 levels and other clinical indicators of severity, suggesting its role as a reliable biomarker.
• The assessment was conducted through clinical evaluations and laboratory analyses of patient samples diagnosed with interstitial lung disease.
• The findings highlight the potential for MMP2 to guide clinical assessments, but further validation in larger cohorts is needed.